Key points are not available for this paper at this time.
A cytochrome b/c 1 complex which catalyses the reduction of cytochrome c by ubiquinol has been isolated from Rhodopseudomonas sphaeroides GA. It contains two hemes b and substoichiometric amounts of ubiquinone‐10 and of the Rieske Fe‐S center per cytochrome c 1 , and is essentially free of reaction center and bacteriochlorophyll. The complex consists of three major polypeptides with apparent molecular masses of 40, 34 and 25 kDa. The 34‐kDa polypeptide carries heme. Cytochrome c 1 has a midpoint potential of 285 mV. For cytochrome b two midpoint potentials, at 50 and –60 mV, at pH 7.4, can be derived if one assumes two components of equal amount. Ubiquinol–cytochrome c oxidoreductase activity is specific for ubiquinol and bacterial cytochromes c , and is inhibited by antimycin A and 5‐ n ‐undecyl‐6‐hydroxy‐4,7‐dioxobenzothiazole. The complex shows oxidant‐induced reduction of cytochrome b.
Gabellini et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: